{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:13:16Z","timestamp":1779120796062,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00266-025-05550-z","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:45:44Z","timestamp":1767804344000},"page":"3427-3437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of LetibotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Systematic Review and Meta-Analysis of RCTs"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3823-4804","authenticated-orcid":false,"given":"Musa","family":"Masood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2442-8812","authenticated-orcid":false,"given":"Rao Sikandar Shamim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9697-524X","authenticated-orcid":false,"given":"Saad","family":"Masood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8770-1763","authenticated-orcid":false,"given":"Umm E. Aimen","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8859-4653","authenticated-orcid":false,"given":"Sayyam","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"5550_CR1","doi-asserted-by":"crossref","unstructured":"Maio M, Rzany B. Botulinum toxin in aesthetic medicine. Springer; 2007.","DOI":"10.1007\/978-3-540-34095-9_7"},{"key":"5550_CR2","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/DSS.0000000000000146","volume":"41","author":"S Dayan","year":"2015","unstructured":"Dayan S, Coleman WP, Dover JS, et al. Effects of OnabotulinumtoxinA treatment for crow\u2019s feet lines on patient-reported outcomes. Dermatol Surg. 2015;41:S67\u201374. https:\/\/doi.org\/10.1097\/DSS.0000000000000146.","journal-title":"Dermatol Surg"},{"key":"5550_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojac077","author":"H Jones","year":"2022","unstructured":"Jones H, Faulkner H, Losken A. The psychological impact of aesthetic surgery: a mini-review. Aesthet Surg J Open Forum. 2022. https:\/\/doi.org\/10.1093\/asjof\/ojac077.","journal-title":"Aesthet Surg J Open Forum"},{"key":"5550_CR4","doi-asserted-by":"crossref","unstructured":"Reznik AV. The pharmacology of botulinum toxin type A. In: Botulinum toxin - recent topics and applications. IntechOpen;  2022.","DOI":"10.17116\/plast.hirurgia202101177"},{"key":"5550_CR5","first-page":"171","volume":"11","author":"J Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A. The evolution of botulinum neurotoxin type A for cosmetic applications. J Cosmet Laser Ther. 2007;11:171\u201380.","journal-title":"J Cosmet Laser Ther"},{"key":"5550_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CCID.S5482","volume":"3","author":"L Winter","year":"2009","unstructured":"Winter L, Spiegel J. Botulinum toxin type-A in the treatment of glabellar lines. Clin Cosmet Investig Dermatol. 2009;3:1\u20134. https:\/\/doi.org\/10.2147\/CCID.S5482.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5550_CR7","first-page":"159","volume":"29","author":"TC Flynn","year":"2006","unstructured":"Flynn TC. Update on botulinum toxin. Semin Cutan Med Surg. 2006;29:159\u201369.","journal-title":"Semin Cutan Med Surg"},{"key":"5550_CR8","unstructured":"U.S. Food and Drug Administration. FDA approves Letybo for moderate to severe glabellar lines. FDA News Release; 2024."},{"key":"5550_CR9","first-page":"NP1572","volume":"41","author":"DS Mueller","year":"2022","unstructured":"Mueller DS, et al. Efficacy and safety of Letibotulinumtoxin A in a phase 3, randomized, double-blind, placebo-controlled study for the treatment of moderate to severe glabellar lines. Aesthet Surg J. 2022;41:NP1572\u201384.","journal-title":"Aesthet Surg J"},{"key":"5550_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/DSS.0000000000004152","volume":"50","author":"SE Cox","year":"2024","unstructured":"Cox SE, Kaufman-Janette J, Cohen JL, et al. LetibotulinumtoxinA attenuates the psychological burden of glabellar lines and is associated with high subject satisfaction in phase 3 clinical trials. Dermatol Surg. 2024;50:535\u201341. https:\/\/doi.org\/10.1097\/DSS.0000000000004152.","journal-title":"Dermatol Surg"},{"key":"5550_CR11","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane; 2024. Available from www.training.cochrane.org\/handbook."},{"key":"5550_CR12","doi-asserted-by":"crossref","unstructured":"Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. BMJ Books; 2001.","DOI":"10.1002\/9780470693926"},{"key":"5550_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00266-022-03018-y","volume":"47","author":"X Li","year":"2023","unstructured":"Li X, Sui C, Xia X, Chen X. Efficacy and safety of Botulinum toxin type A for treatment of glabellar lines: a network meta-analysis of randomized controlled trials. Aesthetic Plast Surg. 2023;47:365\u201377. https:\/\/doi.org\/10.1007\/s00266-022-03018-y.","journal-title":"Aesthetic Plast Surg"},{"key":"5550_CR14","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/jdv.12881","volume":"29","author":"B Molina","year":"2015","unstructured":"Molina B, Grangier Y, Mole B, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol. 2015;29:1382\u20138. https:\/\/doi.org\/10.1111\/jdv.12881.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"5550_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/dsu.12160","volume":"39","author":"C Hanke","year":"2013","unstructured":"Hanke C, Narins R, Brandt F, et al. A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of IncobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint. Dermatol Surg. 2013;39(6):891\u20139. https:\/\/doi.org\/10.1111\/dsu.12160.","journal-title":"Dermatol Surg"},{"key":"5550_CR16","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.738913","author":"M Moers-Carpi","year":"2012","unstructured":"Moers-Carpi M, Dirschka T, Feller-Heppt G, et al. A randomised, double-blind comparison of 20 units of OnabotulinumtoxinA with 30 units of IncobotulinumtoxinA for glabellar lines. J Cosmet Laser Ther. 2012. https:\/\/doi.org\/10.3109\/14764172.2012.738913.","journal-title":"J Cosmet Laser Ther"},{"key":"5550_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1067\/mjd.2002.121356","volume":"46","author":"JA Carruthers","year":"2002","unstructured":"Carruthers JA, Lowe NJ, Menter MA, al et,. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"5550_CR18","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","volume":"33","author":"GD Monheit","year":"2007","unstructured":"Monheit GD, Carruthers A, Brandt F, al et,. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg. 2007;33:S51\u20139.","journal-title":"Dermatol Surg"},{"key":"5550_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12317","author":"B Ahn","year":"2013","unstructured":"Ahn B, Kim Y, Kim H, et al. Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians. Dermatol Surg. 2013. https:\/\/doi.org\/10.1111\/dsu.12317.","journal-title":"Dermatol Surg"},{"key":"5550_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/11530110-000000000-00000","volume":"11","author":"TC Flynn","year":"2010","unstructured":"Flynn TC. Botulinum toxin: examining duration of effect in facial aesthetic applications. Am J Clin Dermatol. 2010;11:183\u201397.","journal-title":"Am J Clin Dermatol"},{"key":"5550_CR21","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2147\/CCID.S470437","volume":"17","author":"HM Al-Atif","year":"2013","unstructured":"Al-Atif HM, Alqarni AM, Almuntashiri AA, et al. Satisfaction among recipients of cosmetic facial filling procedures at dermatology clinics in Saudi Arabia: a national study. Clin Cosmet Investig Dermatol. 2024;17:2465\u201374. https:\/\/doi.org\/10.2147\/CCID.S470437.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5550_CR22","doi-asserted-by":"publisher","first-page":"e1919325","DOI":"10.1001\/jamanetworkopen.2019.19325","volume":"3","author":"PB Imrey","year":"2020","unstructured":"Imrey PB. Limitations of meta-analyses of studies with high heterogeneity. JAMA Netw Open. 2020;3:e1919325. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.19325.","journal-title":"JAMA Netw Open"},{"key":"5550_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/PPA.S497415","volume":"19","author":"D Kang","year":"2025","unstructured":"Kang D, Kang E, Choi K, et al. Development and validation of facial line distress scale-glabellar lines (FINE-GL). Patient Prefer Adherence. 2025;19:419\u201329. https:\/\/doi.org\/10.2147\/PPA.S497415.","journal-title":"Patient Prefer Adherence"},{"key":"5550_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004;20:981\u201390. https:\/\/doi.org\/10.1185\/030079904125003962.","journal-title":"Curr Med Res Opin"},{"key":"5550_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PRS.0000000000006327","volume":"145","author":"J Carruthers","year":"2019","unstructured":"Carruthers J, Fagien S, Joseph J, et al. \u201cDaxibotulinumtoxinA in the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Plast Reconstr Surg. 2019;145:1. https:\/\/doi.org\/10.1097\/PRS.0000000000006327.","journal-title":"Plast Reconstr Surg"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-025-05550-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:58:47Z","timestamp":1779119927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-025-05550-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5550"],"URL":"https:\/\/doi.org\/10.1007\/s00266-025-05550-z","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}